Fetal lipoprotein changes in pre-eclampsia.
OBJECTIVE
To evaluate the impact of maternal lipid changes upon the fetus in pre-eclampsia (PE) by evaluating lipid profile simultaneously in maternal and umbilical cord blood (UCB).


METHODS
Case-control study performed on healthy and pre-eclamptic pregnant women and their neonates.


METHODS
The Department of Obstetrics and Gynecology, Hospital S. Joao and Faculty of Pharmacy, Porto, Portugal.


METHODS
Forty-two healthy pregnancies and 46 pregnancies complicated with PE. Methods. Total cholesterol (TChol), HDL-cholesterol (HDLc), LDL-cholesterol (LDLc) and triglycerides (TG) levels were determined using enzymatic methods. Apolipoprotein (apo) A-I, apoB and lipoprotein (a) [Lp(a)] values were measured by immunoturbidimetry.


METHODS
Fetal and maternal plasma levels of TChol, HDLc, LDLc, TG, apoA-I, apoB and Lp(a).


RESULTS
Pre-eclamptic women presented significantly higher values for TChol, LDLc, HDLc, TG, apoA-I and apoB compared to normal pregnant women. In the UCB from pre-eclamptic pregnancies, we observed significantly lower values for HDLc and apoA-I, and significantly higher TG concentrations and LDLc/HDLc ratio when compared to normal cases. A positive correlation was observed between maternal TG levels and proteinuria, a marker of PE severity (r =0.40, p <0.01).


CONCLUSIONS
Our data suggest that pre-eclamptic pregnancy is associated with an enhanced hyperlipidemia, which seems to have a negative impact on fetal lipid profile, as reflected by a higher atherogenic LDLc/HDLc ratio and higher TG levels. These children, born of women with PE, may deserve a closer clinical follow-up later in life.
Catarino
Cristina
C
Instituto Biologia Molecular e Celular (IBMC), Universidade Porto, Porto, Portugal. tinacris_cat@hotmail.com
Rebelo
Irene
I
Belo
Luis
L
Rocha-Pereira
Petronila
P
Rocha
Susana
S
Castro
Elisabeth Bayer
EB
Patrício
Belmiro
B
Quintanilha
Alexandre
A
Santos-Silva
Alice
A
D000328:Adult; D016022:Case-Control Studies; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood*; D007231:Infant, Newborn; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood
D008055:Lipids; D008074:Lipoproteins